Early Type 2 Diabetes Care Charleston SC - Why Starting Early Matters | Hope Integrative Medicine
October 30, 2026 · 1:15
Take control of your type 2 diabetes early to prevent complications like nerve damage, heart disease, and kidney failure. Expert guidance from Charleston healthcare providers.
Looking for a Primary Care Provider?
Checkups, preventive care and ongoing care for chronic conditions in West Ashley, Charleston. New patients are often able to be scheduled within a week of requesting an appointment. Schedule an appointment today.
Transcript
The benefits of early management of type 2 diabetes. Here are three things to know. Research shows that good blood sugar control established soon after diagnosis keeps protecting you for years. In landmark research, starting insulin or sulfonylurea tablets early was linked to 17 percent fewer heart attacks, and 26 percent fewer complications such as kidney failure and vision loss. Over time, high blood sugar can injure nerves, causing numbness, tingling or burning pain in the hands and feet. It can damage the filtering system of the kidneys and the blood vessels of the eyes. And type 2 diabetes raises the risk of heart disease and stroke. A diabetes plan brings several tools together. It includes checking your blood sugar, a nutrition strategy and regular activity, such as 150 minutes of moderate exercise a week plus strength training. Depending on your needs, medicines may include metformin, often the first choice, GLP-1 medicines, or insulin when others are not enough. Read the full article at hopeintegrativemed.com.
Frequently Asked Questions
It describes how good blood sugar control established early after a type 2 diabetes diagnosis continues to protect you for years to come.
Starting insulin or sulfonylurea tablets early was linked to 17 percent fewer heart attacks, 26 percent fewer diabetes complications such as kidney failure and vision loss, and 10 percent lower death rates.
Depending on your needs, options may include metformin, often the first-line treatment, SGLT2 inhibitors, GLP-1 medicines, and insulin when other medicines are not enough.
